Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

XRAY

DENTSPLY Sirona Inc

Mar 20 • 04:00PM ET

10.95

-0.31 -2.75 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ALGN HSIC STE SYK PDCO BDX HOLX MTD ZM BIO

| Held by: VTI IJH VB VBR VXF MDY VYM IJJ SPMD SCHA

Index	-	P/E	-	EPS (ttm)	-3.00	Insider Own	0.66%	Shs Outstand	199.60M	Perf Week	-5.11%
Market Cap	2.19B	Forward P/E	7.03	EPS next Y	1.56	Insider Trans	-0.22%	Shs Float	198.44M	Perf Month	-12.54%
Enterprise Value	4.33B	PEG	2.45	EPS next Q	0.31	Inst Own	107.18%	Short Float	6.53%	Perf Quarter	-4.20%
Income	-598.00M	P/S	0.59	EPS this Y	-10.53%	Inst Trans	-3.44%	Short Ratio	2.74	Perf Half Y	-18.41%
Sales	3.68B	P/B	1.63	EPS next Y	8.83%	ROA	-10.70%	Short Interest	12.97M	Perf YTD	-4.20%
Book/sh	6.71	P/C	6.71	EPS next 5Y	2.87%	ROE	-36.45%	52W High	17.18 -36.26%	Perf Year	-29.81%
Cash/sh	1.63	P/FCF	21.03	EPS past 3/5Y	12.05% -51.27%	ROIC	-17.35%	52W Low	9.85 11.17%	Perf 3Y	-70.40%
Dividend Est.	-	EV/EBITDA	7.16	Sales past 3/5Y	-2.10% 1.95%	Gross Margin	50.00%	Volatility	4.29% 5.29%	Perf 5Y	-82.55%
Dividend TTM	0.64 (5.84%)	EV/Sales	1.18	EPS Y/Y TTM	34.18%	Oper. Margin	6.88%	ATR (14)	0.64	Perf 10Y	-81.97%
Dividend Ex-Date	Dec 26, 2025	Quick Ratio	1.03	Sales Y/Y TTM	-2.98%	Profit Margin	-16.25%	RSI (14)	35.45	Recom	2.56
Dividend Gr. 3/5Y	8.58% 9.86%	Current Ratio	1.51	EPS Q/Q	66.18%	SMA20	-13.20%	Beta	1.00	Target Price	14.62
Payout	-	Debt/Eq	1.84	Sales Q/Q	6.19%	SMA50	-13.44%	Rel Volume	1.34	Prev Close	11.26
Employees	14000	LT Debt/Eq	1.57	Earnings	Feb 26 AMC	SMA200	-17.21%	Avg Volume	4.73M	Price	10.95
IPO	Aug 12, 1987	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.70% 3.76%	Trades		Volume	6,335,532	Change	-2.75%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-19-26	Upgrade	BofA Securities	Neutral → Buy	$17
Dec-09-25	Initiated	Barclays	Underweight	$12
Nov-07-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-15-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$14
Mar-13-25	Downgrade	Needham	Buy → Hold
Feb-14-25	Initiated	Wells Fargo	Equal Weight	$20
Jan-23-25	Downgrade	Jefferies	Buy → Hold	$30 → $20
Jan-07-25	Downgrade	Evercore ISI	Outperform → In-line	$20
Dec-04-24	Initiated	Mizuho	Neutral	$21
Nov-07-24	Downgrade	Leerink Partners	Outperform → Market Perform
Oct-25-24	Reiterated	Needham	Buy	$34 → $29
Aug-20-24	Reiterated	Needham	Buy	$34
Feb-26-24	Initiated	Leerink Partners	Outperform	$42
Nov-16-23	Initiated	Needham	Buy	$35
Nov-10-23	Upgrade	William Blair	Mkt Perform → Outperform
Jan-12-23	Upgrade	William Blair	Underperform → Mkt Perform
Aug-05-22	Downgrade	William Blair	Mkt Perform → Underperform
Jun-02-22	Upgrade	UBS	Neutral → Buy	$58 → $47
Apr-20-22	Downgrade	William Blair	Outperform → Mkt Perform
Apr-20-22	Downgrade	Piper Sandler	Overweight → Neutral	$46

Show Previous Ratings

Mar-17-26 07:59AM	Is Align Technology Stock Outperforming the Nasdaq? (Barchart)
Mar-09-26 08:30AM	First-ever Dental Dedicated MRI Validated in Clinical Trial and Cleared by FDA for Advanced Soft-Tissue Diagnostics (GlobeNewswire)
12:35AM	3 Stocks Under $50 Walking a Fine Line (StockStory)
Mar-06-26 10:26AM	Dentsply Sirona (XRAY) Added by Ariel Fund as Strategic Reset Targets Long-Term Growth (Insider Monkey)
Mar-03-26 04:15PM	Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026 (GlobeNewswire) -7.06%
09:15AM	Loading…
09:15AM	Don't Overlook Dentsply (XRAY) International Revenue Trends While Assessing the Stock (Zacks)
Feb-28-26 07:31AM	Dentsply (XRAY) Rebounds 15.5% on Share Buyback (Insider Monkey)
Feb-27-26 01:42PM	Bank, Private-Equity Stock Rout Deepens As AI Fears Mount: What's Moving Markets Friday? (Benzinga) +15.50%
12:39PM	DENTSPLY SIRONA Q4 Earnings Call Highlights (MarketBeat)
12:36PM	Why Are Dentsply Sirona (XRAY) Shares Soaring Today (StockStory)
09:40AM	XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative (Zacks)
08:30AM	DENTSPLY SIRONA Inc. Q4 2025 Earnings Call Summary (Moby)
02:37AM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)
12:06AM	Dentsply Sirona Inc (XRAY) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Shifts (GuruFocus.com)
Feb-26-26 06:00PM	Dentsply (XRAY) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:30PM	Loading…
05:30PM	Dentsply International (XRAY) Q4 Earnings Miss Estimates (Zacks)
04:51PM	Dentsply Sirona's (NASDAQ:XRAY) Q4 CY2025 Sales Top Estimates, Stock Soars (StockStory)
04:01PM	Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook (GlobeNewswire)
Feb-25-26 08:00PM	HALPER SADEH LLC ENCOURAGES DENTSPLY SIRONA INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
09:15AM	Exploring Analyst Estimates for Dentsply (XRAY) Q4 Earnings, Beyond Revenue and EPS (Zacks)
06:08AM	Dentsply Sirona Earnings: What To Look For From XRAY (StockStory)
Feb-24-26 04:30PM	Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors (GlobeNewswire)
09:00AM	Dentsply Sirona and Burkhart Dental Supply Announce Expanded Distribution Partnership to Include Dental Technology Equipment (GlobeNewswire)
07:35AM	Henry Schein (HSIC) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Feb-23-26 08:46AM	DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-19-26 10:02AM	Stocks Retreat on AI Concerns and Geopolitical Risks (Barchart)
10:00AM	Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-09-26 07:40AM	Becton Dickinson (BDX) Beats Q1 Earnings and Revenue Estimates (Zacks)
Feb-06-26 07:52PM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research) +9.82%
Feb-05-26 04:15PM	Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26 (GlobeNewswire)
05:30PM	Loading…
Feb-04-26 05:30PM	Lifevantage (LFVN) Q2 Earnings and Revenues Lag Estimates (Zacks)
Jan-28-26 11:03PM	Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Jan-26-26 08:15AM	Wellspect HealthCare Launches Surity Female External Catheter Improving Care for Women Living with Severe Urinary Incontinence (PR Newswire)
Jan-21-26 12:21PM	Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know (StockStory) +5.73%
Jan-15-26 11:43AM	Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Jan-14-26 08:00AM	Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership (GlobeNewswire)
Jan-13-26 04:30PM	Dentsply Sirona and Benco Dental Announce Expanded Partnership to Include Dental Technology Solutions (GlobeNewswire)
08:00AM	Dentsply Sirona Appoints Donald Zurbay to Board of Directors (GlobeNewswire)
Jan-12-26 09:00AM	Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization (GlobeNewswire)
Jan-08-26 07:44AM	Jim Cramer on DENTSPLY SIRONA: "I Think It Absolutely Represents Some Value Here" (Insider Monkey)
Jan-06-26 04:15PM	Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.55%
03:06PM	Why Dentsply Sirona (XRAY) Stock Is Trading Up Today (StockStory)
Dec-24-25 10:34PM	Dental Equipment & Technology Stocks Q3 Results: Benchmarking Dentsply Sirona (NASDAQ:XRAY) (StockStory)
Dec-15-25 08:00AM	Dentsply Sirona Declares Quarterly Cash Dividend (GlobeNewswire)
Dec-11-25 06:39AM	Is Align Technology Stock Underperforming the S&P 500? (Barchart)
Nov-12-25 08:27PM	3 Healthcare Stocks Topping a 2025 List of Dividend Yields (Motley Fool)
Nov-11-25 06:40AM	New Strong Sell Stocks for Nov. 11 (Zacks)
Nov-10-25 09:15AM	Unlocking Dentsply (XRAY) International Revenues: Trends, Surprises, and Prospects (Zacks)
Nov-07-25 10:15AM	Dentsply Sirona CFO departs after six-month tenure (CFO Dive)
Nov-06-25 04:01PM	Dentsply Sirona Inc (XRAY) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) -12.68%
03:12PM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)
11:36AM	Why Dentsply Sirona (XRAY) Shares Are Plunging Today (StockStory)
10:39AM	XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View (Zacks)
10:00AM	Compared to Estimates, Dentsply (XRAY) Q3 Earnings: A Look at Key Metrics (Zacks)
09:15AM	Dentsply International (XRAY) Lags Q3 Earnings Estimates (Zacks)
08:14AM	Dentsply Sirona (NASDAQ:XRAY) Posts Better-Than-Expected Sales In Q3 But Stock Drops 10% (StockStory)
08:00AM	Dentsply Sirona Reports Third Quarter 2025 Results (GlobeNewswire)
Nov-04-25 10:21PM	What To Expect From Dentsply Sirona's (XRAY) Q3 Earnings (StockStory)
08:39AM	DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock? (Zacks)
Oct-30-25 10:00AM	Earnings Preview: Dentsply International (XRAY) Q3 Earnings Expected to Decline (Zacks)
Oct-24-25 10:40AM	Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Oct-15-25 02:01PM	Dentsply Sirona (XRAY) Stock Trades Up, Here Is Why (StockStory)
Oct-13-25 08:01AM	Heartland Value Fund is Monitoring Dentsply Sirona (XRAY) Amid a Deep Discount (Insider Monkey)
Oct-10-25 03:50PM	Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know (StockStory)
Oct-08-25 04:15PM	Dentsply Sirona to Host Third Quarter Conference Call on November 6th (GlobeNewswire)
Oct-02-25 08:30AM	Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization (GlobeNewswire)
Sep-23-25 11:31PM	Spotting Winners: Dentsply Sirona (NASDAQ:XRAY) And Dental Equipment & Technology Stocks In Q2 (StockStory)
Sep-21-25 09:26PM	DENTSPLY SIRONA Inc. (XRAY) Presents Refined Strategy Roadmap At the Morgan Stanley 23rd Annual Global Healthcare Conference (Insider Monkey)
Sep-16-25 09:29AM	Dental Giant DENTSPLY SIRONA Inc. (XRAY) Keeps Wellspect Unit Amid Strong Market Potential (Insider Monkey)
Sep-10-25 09:02AM	Dentsply Sirona Retains Wellspect Following Strategic Review (Zacks)
Sep-08-25 08:30AM	Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives (GlobeNewswire)
12:03AM	3 Reasons to Avoid XRAY and 1 Stock to Buy Instead (StockStory)
Aug-26-25 04:30PM	Dentsply Sirona to Participate in Upcoming Investor Conferences (GlobeNewswire)
08:22AM	Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand (Zacks)
Aug-21-25 09:45AM	Is the Options Market Predicting a Spike in DENTSPLY Stock? (Zacks)
Aug-19-25 01:41PM	Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway. (Barrons.com)
05:59AM	Medtronic to add two new directors after Elliott takes large stake (Reuters)
Aug-18-25 04:06AM	Dental CAD-CAM Market Forecast and Company Analysis Report 2025-2029, with 3Shape, Align Technology, Carestream Dental, Dentsply Sirona, Jensen Dental, Schutz Dental, and Yenadent (GlobeNewswire)
Aug-14-25 10:35AM	Dental Implants and Prosthetics Company Evaluation Report 2025 \| Institut Straumann, Envista, and Dentsply Sirona Lead with Innovation and Expansive Portfolios (GlobeNewswire)
Aug-11-25 09:15AM	International Markets and Dentsply (XRAY): A Deep Dive for Investors (Zacks)
Aug-08-25 09:45AM	Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term (Zacks)
07:25AM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)
Aug-07-25 02:15PM	Dentsply Sirona Maintains Outlook Despite Sales Decline (Benzinga)
01:49PM	Dentsply Sirona's (NASDAQ:XRAY) Q2 Earnings Results: Revenue In Line With Expectations (StockStory)
11:06AM	XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up (Zacks)
09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:30AM	Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:15AM	Dentsply International (XRAY) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:49AM	Dental Soft Tissue Regeneration Markets 2021-2024 & 2025-2031 with Analyst Recommendations - Developing Cost-effective, Faster-acting Regenerative Materials / Untapped Potential in Emerging Markets (GlobeNewswire)
06:00AM	Dentsply Sirona Reports Second Quarter 2025 Results (GlobeNewswire)
Aug-06-25 12:50PM	Countdown to the 9th MedDev eMarketing Summit 2025 (San Diego, CA, United States - August 7-8, 2025) (GlobeNewswire)
Aug-05-25 11:10PM	Dentsply Sirona (XRAY) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 11:40AM	XRAY or MMSI: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Should Value Investors Buy Dentsply Sirona (XRAY) Stock? (Zacks)
08:35AM	DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-31-25 10:00AM	Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks) -7.50%
Jul-30-25 05:30PM	Align Technology (ALGN) Q2 Earnings and Revenues Lag Estimates (Zacks)
Jul-28-25 09:50AM	Here's Why Dentsply International (XRAY) is a Strong Momentum Stock (Zacks)
12:01AM	Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-22-25 11:16AM	Analyst Report: DENTSPLY SIRONA Inc. (Morningstar Research)

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LUCIER GREGORY T	Director	Mar 09 '26	Buy	12.45	15,000	186,675	65,000	Mar 09 04:20 PM
Forbes James D	Director	Mar 09 '26	Buy	12.48	5,000	62,400	10,000	Mar 09 04:19 PM
LUCIER GREGORY T	Director	Mar 02 '26	Buy	14.24	27,555	392,521	27,555	Mar 03 07:12 PM
LUCIER GREGORY T	Director	Mar 03 '26	Buy	14.03	22,445	314,858	50,000	Mar 03 07:12 PM
LUCIER GREGORY T	DIRECTOR	Dec 08 '25	Proposed Sale	11.10	82,200	912,420		Dec 11 08:16 PM
LUCIER GREGORY T	Director	Dec 08 '25	Sale	11.14	82,200	915,708	0	Dec 10 04:26 PM
VARON LESLIE F	Director	Nov 24 '25	Buy	10.71	9,337	99,999	57,343	Nov 25 05:26 PM

Open in Screener

AVTR

Avantor Inc

Mar 20 • 04:00PM ET

7.51

-0.10 -1.31 %

Healthcare • Medical Instruments & Supplies • USA • NYSE

Peers: TMO DHR A BRKR STE BIO WAT MTD IQV IDXX

| Held by: VTI IJH VB VBR VXF MDY IJJ SPMD IWR VHT

Index	-	P/E	-	EPS (ttm)	-0.78	Insider Own	2.80%	Shs Outstand	682.00M	Perf Week	-5.30%
Market Cap	5.12B	Forward P/E	8.87	EPS next Y	0.85	Insider Trans	4.44%	Shs Float	662.99M	Perf Month	-18.46%
Enterprise Value	8.89B	PEG	20.17	EPS next Q	0.16	Inst Own	100.58%	Short Float	5.92%	Perf Quarter	-32.34%
Income	-530.20M	P/S	0.78	EPS this Y	-12.60%	Inst Trans	1.84%	Short Ratio	3.29	Perf Half Y	-41.60%
Sales	6.55B	P/B	0.92	EPS next Y	7.58%	ROA	-4.44%	Short Interest	39.22M	Perf YTD	-34.47%
Book/sh	8.16	P/C	14.02	EPS next 5Y	0.44%	ROE	-9.20%	52W High	16.78 -55.26%	Perf Year	-53.87%
Cash/sh	0.54	P/FCF	10.35	EPS past 3/5Y	- -	ROIC	-5.50%	52W Low	7.46 0.67%	Perf 3Y	-64.22%
Dividend Est.	-	EV/EBITDA	9.01	Sales past 3/5Y	-4.46% 0.49%	Gross Margin	31.50%	Volatility	4.44% 4.06%	Perf 5Y	-73.83%
Dividend TTM	-	EV/Sales	1.36	EPS Y/Y TTM	-174.31%	Oper. Margin	8.80%	ATR (14)	0.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.18	Sales Y/Y TTM	-3.41%	Profit Margin	-8.09%	RSI (14)	23.85	Recom	2.95
Dividend Gr. 3/5Y	- -	Current Ratio	1.78	EPS Q/Q	-89.48%	SMA20	-9.90%	Beta	1.01	Target Price	10.60
Payout	0.00%	Debt/Eq	0.74	Sales Q/Q	-1.36%	SMA50	-24.74%	Rel Volume	1.04	Prev Close	7.61
Employees	13500	LT Debt/Eq	0.73	Earnings	Feb 11 BMO	SMA200	-37.42%	Avg Volume	11.91M	Price	7.51
IPO	May 17, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.29% 1.61%	Trades		Volume	12,422,752	Change	-1.31%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$8.50
Jan-05-26	Downgrade	Evercore ISI	Outperform → In-line	$12
Dec-17-25	Downgrade	Jefferies	Hold → Underperform	$9
Dec-15-25	Downgrade	BofA Securities	Buy → Neutral	$13
Nov-04-25	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-30-25	Downgrade	JP Morgan	Overweight → Neutral	$12
Oct-30-25	Downgrade	Barclays	Overweight → Equal Weight	$12
Aug-01-25	Downgrade	Jefferies	Buy → Hold
Apr-29-25	Downgrade	Goldman	Buy → Neutral	$14
Apr-28-25	Downgrade	TD Cowen	Buy → Hold	$15.50
Apr-28-25	Downgrade	Stifel	Buy → Hold	$14
Apr-28-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-17-25	Downgrade	UBS	Buy → Neutral	$29 → $25
Aug-28-24	Initiated	Wells Fargo	Overweight	$30
Jul-10-24	Downgrade	Citigroup	Buy → Neutral	$30 → $23
Jan-04-24	Upgrade	Evercore ISI	In-line → Outperform	$19.50 → $26
Dec-11-23	Upgrade	TD Cowen	Market Perform → Outperform	$21 → $28
Sep-28-23	Initiated	Bernstein	Mkt Perform	$22
Jul-31-23	Downgrade	William Blair	Outperform → Mkt Perform
Jul-31-23	Downgrade	Evercore ISI	Outperform → In-line	$22 → $21

Show Previous Ratings

Mar-06-26 09:31AM	Marvell upgraded, Trade Desk downgraded: Wall Street's top analyst calls (The Fly)
Mar-05-26 04:57AM	New Strong Sell Stocks for March 5th (Zacks)
Mar-04-26 12:41PM	Looking For A Rebound? China Tech and Emerging Markets Top Oversold List (Benzinga)
Mar-02-26 05:19AM	New Strong Sell Stocks for March 2nd (Zacks)
Feb-27-26 02:45PM	UBS, Jefferies, and BofA Cut Price Targets on Avantor (AVTR) (Insider Monkey)
09:26AM	Loading…
Feb-26-26 09:26AM	Broyhill Views Avantor (AVTR) as a Costly Mistake. Here's Why (Insider Monkey)
Feb-18-26 04:36AM	Archrock and Avantor have been highlighted as Zacks Bull and Bear of the Day (Zacks)
04:30AM	Bear of the Day: Avantor (AVTR) (Zacks)
12:36AM	The 5 Most Interesting Analyst Questions From Avantor's Q4 Earnings Call (StockStory)
Feb-17-26 01:43AM	New Strong Sell Stocks for February 17th (Zacks)
Feb-14-26 01:25AM	Avantor (AVTR) PT Lowered to $11 by BofA Following Soft FY 2026 Guidance (Insider Monkey)
Feb-12-26 10:41AM	AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline (Zacks) -5.19%
12:33AM	AVTR Q4 Deep Dive: Strategic Overhaul and Market Transition Shape 2026 Outlook (StockStory)
Feb-11-26 02:23PM	Software Slump Resumes, Bitcoin Plunges To 66,000: What's Moving Markets Wednesday? (Benzinga) -13.62%
02:01PM	Avantor Inc (AVTR) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
01:50PM	Loading…
01:50PM	Avantor Q4 Earnings Call Highlights (MarketBeat)
01:42PM	Avantor Falls To Critical Levels As CEO Signals Investment Year Amid Soft Guidance (Benzinga)
12:32PM	Avantor, Inc. Q4 2025 Earnings Call Summary (Moby)
09:30AM	Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:15AM	Avantor, Inc. (AVTR) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
06:17AM	Avantor (NYSE:AVTR) Surprises With Q4 CY2025 Sales But Stock Drops (StockStory)
06:05AM	Avantor Reports Fourth Quarter and Full Year 2025 Results (PR Newswire)
Feb-09-26 10:08PM	Avantor (AVTR) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
Feb-06-26 09:40AM	Should Value Investors Buy Avantor (AVTR) Stock? (Zacks)
Feb-05-26 11:40AM	AVTR or ALHC: Which Is the Better Value Stock Right Now? (Zacks)
Feb-04-26 07:40AM	Cencora (COR) Q1 Earnings Top Estimates (Zacks)
Feb-01-26 09:21AM	Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Benzinga)
Jan-12-26 08:05AM	Avantor to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026 (PR Newswire)
Jan-08-26 08:29AM	Here's Why You Should Hold Avantor Stock in Your Portfolio for Now (Zacks)
Jan-05-26 08:05AM	Avantor to Participate in 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
09:44AM	Loading…
Jan-02-26 09:44AM	What Does Wall Street Think About Avantor, Inc. (AVTR)? (Insider Monkey)
Jan-01-26 11:04PM	3 Reasons to Avoid AVTR and 1 Stock to Buy Instead (StockStory)
Dec-26-25 09:00AM	Investors in Avantor, Inc. Should Contact Levi & Korsinsky Before December 29, 2025 to Discuss Your Rights - AVTR (PR Newswire)
Dec-25-25 11:50PM	Avantor Appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle East & Africa (NewMediaWire)
Dec-24-25 04:32AM	New Strong Sell Stocks for Dec. 24 (Zacks)
Dec-23-25 09:00AM	Avantor, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 29, 2025 to Discuss Your Rights - AVTR (PR Newswire)
Dec-22-25 03:15AM	New Strong Sell Stocks for Dec. 22 (Zacks)
Dec-18-25 10:31PM	Reflecting On Research Tools & Consumables Stocks' Q3 Earnings: Avantor (NYSE:AVTR) (StockStory)
08:05AM	Avantor Appoints Simon Dingemans to its Board of Directors (PR Newswire)
Dec-12-25 09:45AM	Huge Insider Buying in MGM and Salesforce (24/7 Wall St.)
Dec-11-25 07:52AM	Avantor, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVTR (PR Newswire)
Dec-10-25 01:06PM	Why Avantor (AVTR) Stock Is Trading Up Today (StockStory) +8.28%
Dec-09-25 08:42AM	Is the Options Market Predicting a Spike in Avantor Stock? (Zacks)
Dec-08-25 06:13AM	New Strong Sell Stocks for December 8th (Zacks)
Dec-04-25 04:15PM	Avantor Appoints Sanjeev Mehra to its Board of Directors (PR Newswire)
Nov-25-25 08:05AM	Avantor Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology (PR Newswire)
Nov-19-25 08:05AM	Avantor Expands Centralized Service Center Model with Opening of Boston-Area Facility (PR Newswire)
Nov-11-25 04:30AM	Avantor, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVTR (PR Newswire)
Nov-10-25 08:30AM	Avantor Appoints Mary Blenn as Executive Vice President and Chief Operating Officer (PR Newswire)
Nov-05-25 12:36AM	The 5 Most Interesting Analyst Questions From Avantor's Q3 Earnings Call (StockStory)
Nov-03-25 02:43AM	Avantor, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVTR (PR Newswire)
Oct-31-25 05:00PM	Avantor, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights AVTR (Business Wire) +6.97%
03:20PM	Avantor (AVTR) Stock Trades Up, Here Is Why (StockStory)
Oct-30-25 02:02PM	Avantor Stock Plunges as Q3 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
11:26AM	Avantor (AVTR) Loses 23% on Steel Q3 Loss (Insider Monkey)
08:05AM	Avantor Unveils Next-Generation Sterile Sampling Platform and PUPSIT Assemblies (PR Newswire)
01:33AM	AVTR Q3 Deep Dive: Strategic Overhaul Launched Amid Margin and Execution Challenges (StockStory)
Oct-29-25 03:46PM	Why Avantor (AVTR) Shares Are Trading Lower Today (StockStory) -23.21%
09:30AM	Compared to Estimates, Avantor (AVTR) Q3 Earnings: A Look at Key Metrics (Zacks)
07:15AM	Avantor, Inc. (AVTR) Q3 Earnings and Revenues Miss Estimates (Zacks)
06:16AM	Avantor (NYSE:AVTR) Misses Q3 Sales Expectations, Stock Drops 17.9% (StockStory)
06:05AM	Avantor Reports Third Quarter 2025 Results (PR Newswire)
Oct-27-25 11:05PM	Earnings To Watch: Avantor (AVTR) Reports Q3 Results Tomorrow (StockStory)
11:44AM	Teladoc (TDOC) Soars 10.0%: Is Further Upside Left in the Stock? (Zacks)
Oct-24-25 08:07AM	Avantor, BlueWhale Partner Bio to Accelerate CAR-T Cell Therapy Manufacturing (Insider Monkey)
Oct-23-25 08:05AM	Avantor Announces Partnership with p-Chip Corporation to Develop Solutions for Digital Traceability of Smart Consumables (PR Newswire)
Oct-22-25 10:00AM	Earnings Preview: Avantor, Inc. (AVTR) Q3 Earnings Expected to Decline (Zacks)
Oct-21-25 01:41PM	Avantor (AVTR) Stock Trades Up, Here Is Why (StockStory)
12:04AM	Avantor (AVTR): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Oct-17-25 12:23PM	Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing (Zacks)
Oct-15-25 08:05AM	Avantor and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology (PR Newswire)
Oct-13-25 04:05PM	Avantor Announces Board Chairman Transition (PR Newswire)
Oct-03-25 01:05PM	Avantor (AVTR) Stock Is Up, What You Need To Know (StockStory)
08:05AM	Avantor Appoints Gregory T. Lucier to its Board of Directors (PR Newswire)
Oct-02-25 11:35PM	Research Tools & Consumables Stocks Q2 Recap: Benchmarking Avantor (NYSE:AVTR) (StockStory)
Oct-01-25 05:34PM	Avantor (AVTR) Gets Boost From Trump's Pharma Tariffs (Insider Monkey) +9.54%
08:05AM	Avantor to Host Third Quarter 2025 Earnings Call on Wednesday, October 29, 2025 (PR Newswire)
Sep-19-25 09:05AM	Should You Hold Avantor (AVTR)? (Insider Monkey)
Sep-03-25 02:45PM	Why Avantor (AVTR) Stock Is Trading Lower Today (StockStory)
Aug-27-25 04:32PM	Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution (PR Newswire)
Aug-26-25 12:37AM	1 Value Stock to Target This Week and 2 Facing Challenges (StockStory)
Aug-19-25 08:00AM	How To Invest: 10-Day Moving Average Offers Early Exit Signal (Investor's Business Daily)
Aug-13-25 05:51PM	Avantor, Viatris, and Amneal Stocks Trade Up, What You Need To Know (StockStory)
12:12AM	5 Revealing Analyst Questions From Avantor's Q2 Earnings Call (StockStory)
12:05AM	AVTR Q2 Deep Dive: Margin Pressures Mount as Competitive Intensity Rises and Leadership Transition Looms (StockStory)
Aug-11-25 04:15PM	Avantor Surges As Activist Investor Takes Aim At 'Self-Inflicted' Issues (Investor's Business Daily) +5.22%
12:31PM	Why Avantor (AVTR) Stock Is Trading Up Today (StockStory)
12:00PM	Cannabis stocks, Avantor, Albemarle: Trending Tickers (Yahoo Finance Video)
11:24AM	Activist Investor to Push Avantor to Make Changes or Sell Itself (The Wall Street Journal)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:48AM	Stocks to Watch Monday: Nvidia, AMC, Barrick Mining, Intel (The Wall Street Journal)
09:33AM	Avantor Reiterates Shareholder Value Creation Focus (PR Newswire)
08:33AM	Avantor Stock Is Rising. An Activist Wants Changes, Maybe a Sale. (Barrons.com)
07:00AM	Engine Capital Sends Letter to Avantor's Board of Directors Regarding Opportunities to Improve Governance and Unlock Shareholder Value (Business Wire)
Aug-10-25 06:00PM	Activist Investor to Push Avantor to Sell Itself (The Wall Street Journal)
Aug-04-25 12:06PM	AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y (Zacks)
Aug-02-25 10:22AM	Dismal Q2 Earnings Weigh Heavily on Avantor (AVTR) Shares (Insider Monkey)
03:05AM	Avantor Inc (AVTR) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Aug-01-25 12:21PM	Why Avantor (AVTR) Shares Are Plunging Today (StockStory) -15.48%
09:30AM	Avantor (AVTR) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)

Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the Laboratory Solutions segment and Bioscience Production. The Laboratory Solutions segment focuses on research, diagnostic, and quality control workflows. The Bioscience Production segment focuses on high-purity materials for bioprocessing and medical technologies. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MEHRA SANJEEV K	Director	Mar 10 '26	Buy	8.01	125,000	1,001,250	475,000	Mar 11 05:10 PM
LUCIER GREGORY T	Director	Feb 19 '26	Buy	9.16	50,000	458,000	50,000	Feb 23 08:53 PM
SUMME GREGORY L	Director	Feb 12 '26	Buy	9.40	100,000	940,000	400,000	Feb 12 05:24 PM
MEHRA SANJEEV K	Director	Dec 05 '25	Buy	11.09	350,000	3,881,500	350,000	Dec 09 05:11 PM
Ligner Emmanuel	President and CEO	Nov 17 '25	Buy	11.35	87,500	993,125	283,424	Nov 17 05:45 PM
Todd Edwards	officer	Nov 06 '25	Proposed Sale	25.16	29,131	732,926		Nov 06 04:26 PM
SUMME GREGORY L	Director	Oct 30 '25	Buy	11.25	100,000	1,125,000	300,000	Oct 31 09:46 AM
SUMME GREGORY L	Director	Aug 21 '25	Buy	12.56	100,000	1,256,000	200,000	Aug 22 04:15 PM
Eck Steven W	SVP & Chief Accounting Officer	Aug 05 '25	Sale	11.39	3,476	39,592	55,068	Aug 06 04:32 PM
Eck Steven W	Officer	Aug 05 '25	Proposed Sale	11.39	3,476	39,592		Aug 05 10:58 AM
SUMME GREGORY L	Director	May 23 '25	Buy	12.50	30,000	375,000	100,000	May 27 04:58 PM
SUMME GREGORY L	Director	May 22 '25	Buy	12.65	20,000	253,000	70,000	May 22 05:37 PM
SUMME GREGORY L	Director	May 07 '25	Buy	12.00	25,000	300,000	50,000	May 09 04:51 PM
Massaro Joseph R	Director	Apr 29 '25	Buy	12.30	8,100	99,630	35,038	Apr 29 05:58 PM
SUMME GREGORY L	Director	Apr 28 '25	Buy	12.50	25,000	312,500	25,000	Apr 29 05:58 PM
Kang Lan	Director	Apr 28 '25	Buy	12.57	5,000	62,850	35,215	Apr 29 05:58 PM
Peacock Jonathan M	Director	Apr 28 '25	Buy	12.81	8,091	103,646	202,715	Apr 29 05:58 PM

Open in Screener

MRVI

Maravai LifeSciences Holdings Inc

Mar 20 • 04:00PM ET

2.98

-0.05 -1.65 %

Healthcare • Biotechnology • USA • NASD

MRVI Maravai LifeSciences Holdings Inc daily Stock Chart

Peers: TMO DHR ILMN BIO RGEN BMRN BIOX ACRS ALDX APLS

| Held by: VTI IWM VXF IWN IBB VTWO SCHA DFAS VHT PRFZ

Index	RUT	P/E	-	EPS (ttm)	-0.91	Insider Own	28.83%	Shs Outstand	145.32M	Perf Week	-3.25%
Market Cap	766.06M	Forward P/E	-	EPS next Y	-0.15	Insider Trans	0.77%	Shs Float	104.18M	Perf Month	-3.25%
Enterprise Value	1.07B	PEG	-	EPS next Q	-0.05	Inst Own	76.58%	Short Float	10.21%	Perf Quarter	-13.87%
Income	-130.77M	P/S	4.12	EPS this Y	37.46%	Inst Trans	0.86%	Short Ratio	8.30	Perf Half Y	3.47%
Sales	185.74M	P/B	2.04	EPS next Y	18.85%	ROA	-14.70%	Short Interest	10.64M	Perf YTD	-8.31%
Book/sh	1.46	P/C	3.53	EPS next 5Y	24.50%	ROE	-48.64%	52W High	4.11 -27.41%	Perf Year	24.17%
Cash/sh	0.84	P/FCF	-	EPS past 3/5Y	- -	ROIC	-23.23%	52W Low	1.66 78.98%	Perf 3Y	-79.07%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-40.53% -8.15%	Gross Margin	17.01%	Volatility	5.26% 5.99%	Perf 5Y	-91.57%
Dividend TTM	-	EV/Sales	5.78	EPS Y/Y TTM	12.14%	Oper. Margin	-41.84%	ATR (14)	0.20	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.69	Sales Y/Y TTM	-28.34%	Profit Margin	-70.41%	RSI (14)	36.50	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.60	EPS Q/Q	-33.41%	SMA20	-11.43%	Beta	0.39	Target Price	4.33
Payout	-	Debt/Eq	1.72	Sales Q/Q	-11.59%	SMA50	-12.85%	Rel Volume	2.21	Prev Close	3.03
Employees	435	LT Debt/Eq	1.65	Earnings	Feb 25 AMC	SMA200	-1.46%	Avg Volume	1.28M	Price	2.98
IPO	Nov 20, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	43.02% 1.67%	Trades		Volume	2,831,362	Change	-1.65%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral	$9 → $3
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell	$4.25
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$10
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$11 → $10
Apr-10-24	Initiated	Craig Hallum	Buy	$15
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$10 → $8
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral	$18 → $14
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral	$20 → $16
Dec-14-22	Initiated	Deutsche Bank	Buy	$25
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$22
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral	$32 → $17
Aug-25-22	Initiated	Credit Suisse	Outperform	$34
Aug-05-21	Resumed	Credit Suisse	Outperform	$44
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight	$33
Dec-15-20	Initiated	William Blair	Outperform

Show Previous Ratings

Feb-26-26 08:30AM	Maravai LifeSciences Holdings, Inc. Q4 2025 Earnings Call Summary (Moby) +9.20%
02:11AM	Maravai LifeSciences Q4 Earnings Call Highlights (MarketBeat)
Feb-25-26 07:25PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:01PM	Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-09-26 05:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 (Business Wire)
08:00AM	Loading…
Nov-10-25 08:00AM	Maravai LifeSciences Announces November 2025 Investor Conference Schedule (Business Wire) +8.01%
Nov-07-25 12:12AM	Maravai LifeSciences Holdings Inc (MRVI) Q3 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-06-25 06:15PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Maravai LifeSciences Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-04-25 09:05AM	AdaptHealth Corp. (AHCO) Misses Q3 Earnings Estimates (Zacks)
Oct-22-25 04:01PM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 (Business Wire)
Aug-12-25 03:07AM	Maravai LifeSciences Holdings Inc (MRVI) Q2 2025 Earnings Call Highlights: Navigating ... (GuruFocus.com) +30.58%
Aug-11-25 07:00PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -6.36%
04:05PM	Maravai LifeSciences Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-28-25 05:08PM	Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 (GlobeNewswire) -6.42%
04:01PM	Loading…
Jun-25-25 04:01PM	Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer (GlobeNewswire)
Jun-09-25 08:30AM	Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors (GlobeNewswire)
Jun-03-25 10:00AM	TriLink BioTechnologies and Quantoom Biosciences Sign License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
May-21-25 04:22PM	CORRECTION - Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire) -6.25%
04:05PM	Maravai LifeSciences Releases 2024 Sustainability Report (GlobeNewswire)
May-20-25 08:00AM	TriLink BioTechnologies debuts its first mRNA synthesis kit with CleanCap capping technology; Celebrates launch with kit donations to top academic institutions (Business Wire) +10.60%
May-14-25 04:00PM	TriLink BioTechnologies and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines (Business Wire)
May-13-25 09:30AM	Q1 2025 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:11AM	Maravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call Highlights: Navigating Growth ... (GuruFocus.com)
May-12-25 05:20PM	Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +7.07%
04:06PM	Maravai Lifesciences Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 05:10PM	Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-07-25 07:10PM	MariMed Inc. (MRMD) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-05-25 05:47AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
May-01-25 05:20PM	Stryker (SYK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:30AM	Loading…
07:30AM	Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 (GlobeNewswire)
Apr-24-25 12:27PM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Apr-22-25 05:45AM	Investors in Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights - MRVI (PR Newswire) +9.04%
Apr-16-25 06:10PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-15-25 09:35AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-14-25 01:13PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-11-25 01:31PM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations Hagens Berman (GlobeNewswire)
Apr-10-25 11:34AM	QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains? (Zacks) -8.25%
04:37AM	Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman (Newsfile)
Apr-04-25 02:34PM	Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive (Seeking Alpha) -7.62%
Apr-03-25 06:21PM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire)
Apr-01-25 01:23PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
Mar-25-25 12:49PM	Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management? (InsiderMonkey)
Mar-24-25 02:33PM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-22-25 10:30AM	Maravai Lifesciences price target lowered to $5 from $10 at Stifel (TipRanks)
Mar-21-25 08:00PM	Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript (Motley Fool) -5.62%
01:43PM	Shareholders of Maravai LifeSciences Holdings, Inc. Should Contact Levi & Korsinsky Before May 5, 2025 to Discuss Your Rights MRVI (GlobeNewswire)
Mar-20-25 09:00PM	Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript (SeekingAlpha)
Mar-18-25 04:05PM	Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) -5.81%
05:45AM	Maravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRVI (PR Newswire)
Mar-17-25 02:22AM	MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI (PR Newswire) +7.76%
Mar-16-25 09:32AM	3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk (Motley Fool)
Mar-08-25 10:15AM	Maravai LifeSciences Holdings, Inc. (MRVI): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? (Insider Monkey)
Feb-28-25 09:31AM	Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman (PR Newswire) +5.57%
Feb-27-25 06:37PM	Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development (Insider Monkey) -6.15%
Feb-25-25 06:00AM	Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call (GlobeNewswire) -21.70%
Feb-24-25 08:00AM	Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio (Business Wire)
Feb-04-25 04:01PM	TriLink BioTechnologies and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Feb-03-25 06:00AM	TriLink BioTechnologies Partners with Avantor to Expand Nucleic Acid Solutions in Europe (Business Wire)
Jan-28-25 04:01PM	Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies (Business Wire) -8.55%
Jan-20-25 11:02PM	Maravai LifeSciences Holdings, Inc. (MRVI) Stock: An Under $5 Gem with Biggest Upside Potential (Insider Monkey)
Jan-08-25 04:10PM	Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue (GlobeNewswire) -20.88%
Dec-20-24 07:15AM	Maravai Lifesciences initiated with a Neutral at Guggenheim (TipRanks)
Dec-05-24 04:05PM	Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors (GlobeNewswire) -6.00%
Nov-12-24 08:05AM	Maravai LifeSciences Announces November 2024 Investor Conference Schedule (GlobeNewswire)
Nov-09-24 06:51AM	Maravai Lifesciences price target lowered to $9 from $10 at Baird (TipRanks)
Nov-08-24 02:20PM	Q3 2024 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -35.27%
03:15AM	Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript (Motley Fool)
02:34AM	Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-07-24 04:01PM	Maravai LifeSciences Reports Third Quarter 2024 Financial Results (GlobeNewswire)
04:01PM	Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research (Business Wire)
Oct-15-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 (GlobeNewswire)
Oct-09-24 08:03AM	RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter (Insider Monkey)
Sep-24-24 08:12AM	TriLink BioTechnologies & Alphazyme Collaborate to Launch New CleanScribe RNA Polymerase (Business Wire)
Aug-28-24 07:49AM	Cygnus Technologies and TriLink BioTechnologies Collaborate to Launch AccuRes Host Cell DNA Quantification Kits (Business Wire)
Aug-12-24 08:05AM	Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule (GlobeNewswire)
Aug-08-24 12:45AM	Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript (Motley Fool) -6.87%
Aug-07-24 04:05PM	Maravai LifeSciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 04:05PM	Maravai LifeSciences Appoints Trey Martin to Board of Directors (GlobeNewswire)
Jul-10-24 08:00AM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 (GlobeNewswire)
Jul-02-24 04:00PM	Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Jun-20-24 09:15AM	Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics (ACCESSWIRE)
Jun-17-24 09:54AM	Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best (Insider Monkey)
Jun-12-24 02:38AM	Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc (GuruFocus.com)
May-17-24 11:52AM	Maravai (MRVI) Advances in RNA Research With New Collaboration (Zacks)
May-13-24 08:00AM	TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center (Business Wire)
May-09-24 04:18PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript (Insider Monkey) +11.16% +6.09%
04:05PM	Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule (GlobeNewswire)
10:53AM	UBS Raises Price Target on Maravai LifeSciences to $8.50 From $6.50, Maintains Neutral Rating (MT Newswires)
10:11AM	Baird Adjusts Price Target on Maravai LifeSciences to $10 From $8, Keeps Outperform Rating (MT Newswires)
04:02AM	Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ... (GuruFocus.com)
03:15AM	Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript (Motley Fool)
May-08-24 08:57PM	MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	Maravai LifeSciences Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-30-24 07:31AM	TriLink BioTechnologies and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap mRNA Capping Technology (Business Wire)
Apr-18-24 07:36AM	TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production (Business Wire)
Apr-10-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 (GlobeNewswire)
Mar-28-24 04:00PM	Dyadic Reports 2023 Full Year Results and Recent Company Progress (GlobeNewswire)
Mar-19-24 07:48AM	Should You Sell Maravai LifeSciences (MRVI)? (Insider Monkey)

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PRAHALAD MURALI	Former Director	Dec 23 '25	Proposed Sale	3.33	3,951	13,138		Dec 23 03:00 PM
Hopfield Jessica	Former Director	Dec 19 '25	Proposed Sale	3.48	53,951	187,526		Dec 19 04:38 PM
LUCIER GREGORY T	Director	Dec 05 '25	Buy	3.70	51,472	190,446	106,595	Dec 09 04:36 PM
LUCIER GREGORY T	Director	Dec 08 '25	Buy	3.67	48,528	178,098	155,123	Dec 09 04:36 PM
Brust Bernd	Chief Executive Officer	Nov 13 '25	Buy	3.25	216,212	702,689	466,771	Nov 17 04:48 PM
Brust Bernd	Chief Executive Officer	Nov 11 '25	Buy	3.24	157,201	509,331	157,201	Nov 13 05:27 PM
Brust Bernd	Chief Executive Officer	Nov 12 '25	Buy	3.21	93,358	299,679	250,559	Nov 13 05:27 PM

XRAY

DENTSPLY Sirona Inc

AVTR

Avantor Inc

MRVI

Maravai LifeSciences Holdings Inc

Upgrade your FINVIZ experience